Expertise in
9
conditions

Catherine M. Lambert

Universitair Ziekenhuis Brussel
Brussels, BRU, BE 
Expertise in
9
conditions
Universitair Ziekenhuis Brussel
Brussels, BRU, BE 

Overview

Catherine Lambert practices practicing medicine in Brussels, Belgium.

Ms. Lambert is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Hemophilia A, Blood Clots, Acquired Hemophilia, Splenectomy, and Fasciotomy.

She is actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Universitair Ziekenhuis Brussel
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
Enrollment Status: Completed
Publish Date: March 17, 2023
Intervention Type: Drug
Study Drug: Lenalidomide and GA101
Study Phase: Phase 1/Phase 2
IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.
IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 1 Less Clinical Trial

97 Total Publications

Short-term emicizumab in patients with acquired hemophilia A.
Short-term emicizumab in patients with acquired hemophilia A.
Journal: Haematologica
Published: April 03, 2026

Frequently Asked Questions about Catherine M. Lambert

Is Catherine M. Lambert a top-rated expert for Hemophilia A?

MediFind is an objective health platform that identifies experts based on real-world data. Catherine M. Lambert is classified as an Elite expert for Hemophilia A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Catherine M. Lambert participate in research or clinical trials?

Yes. Catherine M. Lambert has published 97 articles and abstracts on conditions like Hemophilia A. You can view a list of Catherine M. Lambert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lambert's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile